Key result
Higher baseline systemic inflammation index is linked to ~58% higher risk of post-TAVR valve deterioration.
Why the study?
With TAVR expanding to younger and lower-risk patients, predictors of long-term bioprosthetic valve durability, particularly host-related mechanisms and the role of systemic inflammation, remain incompletely understood.
Are baseline systemic inflammation, early post-procedural valve hemodynamics, and anatomical characteristics independently associated with long-term hemodynamic valve deterioration in patients undergoing TAVR?
Cohort (n=755)
Are baseline systemic inflammation, early post-procedural valve hemodynamics, and anatomical characteristics independently associated with long-term hemodynamic valve deterioration in patients undergoing TAVR?
Answers are grounded in this paper and cite their sources.
Baseline systemic inflammation and early post-procedural mean transprosthetic gradients are independently associated with long-term hemodynamic valve deterioration after TAVR, suggesting inflammatory biomarkers could enhance risk stratification and surveillance.
Background With the expansion of transcatheter aortic valve replacement (TAVR) to younger and lower-risk patients, long-term bioprosthetic valve durability has become a major clinical concern. While some procedural and anatomical contributors to valve deterioration have been explored, the overall landscape of durability predictors—including host-related mechanisms—remains incompletely understood, and the role of systemic inflammation remains largely unclear Objectives To investigate whether baseline systemic inflammation, early post-procedural valve hemodynamics, and anatomical characteristics are independently associated with long-term hemodynamic valve deterioration (HVD) after TAVR. Methods We performed a retrospective cohort study including 755 patients who underwent TAVR between 2015 and 2025 with echocardiographic follow-up for up to 10 years. HVD was defined according to VARC-3 criteria. Baseline systemic inflammation index (SII) was calculated from pre-procedural blood counts. Associations with HVD were evaluated using multivariable Cox proportional hazards models and a time-dependent matched (risk-set) analysis. Results During follow-up, 102 patients (13.5%) developed HVD. Patients with HVD had significantly higher baseline SII and higher early post-TAVR mean transprosthetic gradients. In multivariable analysis, SII (hazard ratio [HR] 1.58 per 10³ increase; 95% confidence interval [CI] 1.44–1.73), post-TAVR mean gradient (HR 1.46 per 5 mmHg; 95% CI 1.35–1.57), diabetes mellitus, female sex, and left ventricular outflow tract calcification were independently associated with HVD. In time-dependent matched analyses, elevated SII (HR 3.75; 95% CI 1.91–7.37) and higher post-TAVR mean gradient (HR 3.23; 95% CI 1.54–6.77) remained strong predictors of valve deterioration. Conclusions Baseline systemic inflammation and early post-procedural valve hemodynamics are independently associated with long-term hemodynamic valve deterioration after TAVR. Incorporating inflammatory biomarkers may improve risk stratification and surveillance strategies in contemporary TAVR practice.
No takes yet. Share an insight, caveat, or question.
Ayyad et al. (2026) conducted a cohort in Transcatheter aortic valve replacement (TAVR) (n=755). Baseline systemic inflammation index (SII) and early post-TAVR mean transprosthetic gradient vs. Lower baseline SII and lower post-TAVR mean gradient was evaluated on Hemodynamic valve deterioration (HVD) defined according to VARC-3 criteria (HR 1.58 per 10³ SII increase, 95% CI 1.44-1.73). Baseline systemic inflammation index and post-TAVR mean gradient independently predicted hemodynamic valve deterioration.
Synapse has enriched 10 related papers. Consider them for comparative context: